Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1182 | 1066 | 1277 | 898 | 1221 | 1526 |
Fund Return | 18.23% | 6.64% | 27.74% | -3.52% | 4.07% | 4.32% |
Place in category | 35 | 15 | 42 | 56 | 36 | 13 |
% in Category | 41 | 17 | 51 | 75 | 63 | 38 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Sura Seleccion Global E | 85.11B | 24.29 | 5.44 | 10.74 | ||
Sura Seleccion Global F | 85.11B | 24.65 | 5.82 | 11.14 | ||
Sura Seleccion Global H | 85.11B | 25.78 | 6.97 | 12.35 | ||
Sura Seleccion Global C | 85.11B | 24.64 | 5.80 | 11.12 | ||
Sura Seleccion Global D | 85.11B | 25.57 | 6.76 | 12.12 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Santander Accion Glbl Emerg EJECU | 23.35B | 17.74 | 0.85 | 4.73 | ||
Santander Accion Glbl Emerg INVER | 23.35B | 17.54 | 0.47 | 4.10 | ||
Santander Accion Glbl Emerg APV | 23.35B | 19.50 | 3.20 | 6.68 | ||
BICE Best Mercados Emergentes G | 13.39B | 24.87 | -1.32 | 4.90 | ||
Sura Seleccion Acciones Emerg D | 7.18B | 18.78 | -2.98 | 4.91 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
AM SURA EMERG ASIA-FUSDACC | LU2446142643 | 68.52 | - | - | |
Sura Selección Acciones Latam SURA | - | 16.06 | - | - | |
iShares Core MSCI Emerging Markets IMI UCITS | IE00BKM4GZ66 | 14.92 | 34.49 | +0.09% | |
Sura Selección Acciones Chile SURA | - | 0.50 | - | - | |
iShares MSCI Emerging Markets Asia UCITS | IE00B5L8K969 | 0.00 | 179.32 | -0.30% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Sell | Buy | Buy |
Technical Indicators | Strong Sell | Strong Buy | Strong Buy |
Summary | Strong Sell | Strong Buy | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review